21 – 30 of 63
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Epstein–Barr virus infection after adolescence and human herpesvirus 6A as risk factors for multiple sclerosis
(
- Contribution to journal › Article
- 2020
-
Mark
Intensive immunosuppression followed by autologous hematopoietic stem cell transplantation for the treatment of multiple sclerosis
(
- Contribution to journal › Scientific review
-
Mark
Cystatin C Plays a Sex-Dependent Detrimental Role in Experimental Autoimmune Encephalomyelitis
(
- Contribution to journal › Article
-
Mark
Multiple sclerosis among first- and second-generation immigrant groups in Sweden
(
- Contribution to journal › Article
- 2019
-
Mark
Benefit–risk Assessment of Cladribine Using Multi-criteria Decision Analysis (MCDA) for Patients With Relapsing-remitting Multiple Sclerosis
(
- Contribution to journal › Article
-
Mark
Increased Serological Response Against Human Herpesvirus 6A Is Associated With Risk for Multiple Sclerosis
(
- Contribution to journal › Article
- 2018
-
Mark
Cognitive functioning following one-year natalizumab treatment : A non-randomized clinical trial
(
- Contribution to journal › Article
-
Mark
Male factor infertility and risk of multiple sclerosis : A register-based cohort study
(
- Contribution to journal › Article
- 2017
-
Mark
Guidelines for the use of magnetic resonance imaging in diagnosing and monitoring the treatment of multiple sclerosis : Recommendations of the Swedish Multiple Sclerosis Association and the Swedish Neuroradiological Society
(
- Contribution to journal › Article
-
Mark
Low-Frequency Synonymous Coding Variation in CYP2R1 Has Large Effects on Vitamin D Levels and Risk of Multiple Sclerosis
(
- Contribution to journal › Article